EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The component changes of lysophospholipid mediators in colorectal cancer

Chieko Kitamura iD, Hirofumi Sonoda, Hiroaki Nozawa, Kuniyuki Kano, Shigenobu Emoto, Koji Murono, Manabu Kaneko, Masaya Hiyoshi, Kazuhito Sasaki, Takeshi Nishikawa, Yasutaka Shuno, Toshiaki Tanaka und 4 weitere

Tumor Biology · 2019-05 · 41 (5)

DOI: 10.1177/1010428319848616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 01.05.2019. Verfasst von Chieko Kitamura und 15 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although lysophospholipids are known to play an important role in the development and progression of several kinds of cancers, their role in human colorectal cancer is as yet unclear. In this study, we aim to investigate lysophospholipid levels in colorectal cancer tissues to identify lysophospholipids, the levels of which change specifically in colorectal cancers. We used liquid chromatography–tandem mass spectrometry to measure lysophospholipid levels in cancerous and normal tissues from 11 surgical specimens of sigmoid colon cancers, since recent advances in this field have improved detection sensitivities for lysophospholipids. Our results indicate that, in colon cancer tissues, levels of lysophosphatidylinositol and lysophosphatidylserine were significantly higher ( p = 0.025 and p = 0.01, respectively), whereas levels of lysophosphatidic acid were significantly lower ( p = 0.0019) than in normal tissues. Although levels of lysophosphatidylglycerol were higher in colon cancer tissues than in normal tissues, this difference was not found to be significant ( p = 0.11). Fatty acid analysis further showed that 18:0 lysophosphatidylinositol and 18:0 lysophosphatidylserine were the predominant species of lysophospholipids in colon cancer tissues. These components may be potentially involved in colorectal carcinogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAged, 80 and overBiomarkers, TumorCase-Control StudiesColorectal NeoplasmsFemaleHumansLysophospholipidsMaleMiddle AgedPrognosis

Stichwörter der Autor:innen

Lysophospholipidcolon cancerlipidomicsliquid chromatography–tandem mass spectrometrylysophosphatidylinositol

Substanzen

Biomarkers, TumorLysophospholipidslysophosphatidylglycerollysophosphatidylinositollysophosphatidylserinelysophosphatidic acid

Autor:innen und Institutionen

  • 1 Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan.
  • 2 Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

ORCID-Profile: Chieko Kitamura

Zitieren

APA

Kitamura, C., Sonoda, H., Nozawa, H., Kano, K., Emoto, S., Murono, K., Kaneko, M., Hiyoshi, M., Sasaki, K., Nishikawa, T., Shuno, Y., Tanaka, T., Hata, K., Kawai, K., Aoki, J., & Ishihara, S. (2019). The component changes of lysophospholipid mediators in colorectal cancer. Tumor Biology, 41(5). https://doi.org/10.1177/1010428319848616

Vancouver

Kitamura C, Sonoda H, Nozawa H, Kano K, Emoto S, Murono K, et al. The component changes of lysophospholipid mediators in colorectal cancer. Tumor Biology. 2019;41(5). doi:10.1177/1010428319848616

BibTeX
@article{Kitamura2019,
  author = {Kitamura, Chieko and Sonoda, Hirofumi and Nozawa, Hiroaki and Kano, Kuniyuki and Emoto, Shigenobu and Murono, Koji and Kaneko, Manabu and Hiyoshi, Masaya and Sasaki, Kazuhito and Nishikawa, Takeshi and Shuno, Yasutaka and Tanaka, Toshiaki and Hata, Keisuke and Kawai, Kazushige and Aoki, Junken and Ishihara, Soichiro},
  title = {The component changes of lysophospholipid mediators in colorectal cancer},
  journal = {Tumor Biology},
  year = {2019},
  volume = {41},
  number = {5},
  doi = {10.1177/1010428319848616}
}
Kostenlos starten →